3 ways AOA’s pediatric chairside guides can strengthen your next exam
AOA’s pediatric experts share practical strategies for examining and managing patients from infancy through adolescence, including how to apply the…
Vision Insurance 101: What’s Covered, Who Accepts What, and How to Get the Most From Your Plan
Vision insurance can feel more confusing than it needs to be. Between medical plans, vision-specific plans, retailer networks, and government…
FinCEN permanently ends BOI reporting for U.S. businesses
Practice owners no longer need to file beneficial ownership information reports. — Curated from external eye-care sources for opthametry.com readers.…
Connecticut doctors secure Medicaid payment parity for optometry
New law eliminates a longstanding reimbursement disparity and directs an additional $2.27 million in Medicaid funding to optometric care—recognizing the…
Celebrate, empower, advance: Make the most of Paraoptometric Appreciation Month
September is Paraoptometric Appreciation Month, the only formal observance dedicated to honoring optometric staff and recognizing the value they contribute…
MiSight® 1 day* vs. Single Vision Contact Lenses: Why Parents are Choosing a Contact Lens that Does More
MiSight® 1 day* vs. Single Vision Contact Lenses: Why Parents are Choosing a Contact Lens that Does More jscully Wed,…
LOOK Lamina Collection
LOOK introduces Lamina, an eyewear line that reinterprets the metal frame through contemporary, lightweight, dynamic design language. Created to fit…
Agbassio Brings the Complete Council of Seven to SILMO Paris
Following its international debut at MIDO Milano, Agbassio will present its complete collection at SILMO Paris 2026. For the first…
How to handle co-management billing
The role of modifiers in pre- and postoperative care billing. — Curated from external eye-care sources for opthametry.com readers. Read…
Harrow acquires global rights to Tyrvaya
Harrow has acquired the global rights to Tyrvaya from Viatris in a deal worth up to $100 million, according to…
FDA approves Lytenava for wet AMD
The FDA approved Lytenava for the treatment of neovascular age-related macular degeneration, according to a press release from Outlook Therapeutics.…
Noninvasive bioelectric therapy for dry AMD begins pivotal study
A pivotal trial is now underway for i-Lumen AMD, a bioelectric therapy being investigated for intermediate to advanced dry age-related…
Noninvasive bioelectric therapy for dry AMD begins pivotal study
A pivotal trial is now underway for i-Lumen AMD, a bioelectric therapy being investigated for intermediate to advanced dry age-related…
Robots will enhance surgery, not replace humans
Click here to read the Healio Exclusive, “Embrace the future’ of robotics in ophthalmology.”I wrote an earlier perspective on the…
Refractive surgery embraces era of corneal preservation
While laser-based procedures continue to deliver excellent refractive outcomes in appropriate candidates, we now better understand the cumulative impact of…